The S&P/ASX 200 Index (ASX: XJO) is having a disappointing finish to the year. At the time of writing, the benchmark index is down 0.7% to 8,174.7 points.
Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:
The AVITA Medical Inc share price is down 2% to $4.28. This may have been driven by profit taking from some investors after strong gains in recent sessions. For example, the company's shares remain up 14% since this time last week despite today's decline. The catalyst for this has been news that the United States Food and Drug Administration (FDA) gave the thumbs up to its premarket approval (PMA) supplement for RECELL GO mini. AVITA CEO, Jim Corbett, said: "The FDA approval of RECELL GO mini strengthens our ability to provide clinicians with fit-for-purpose solutions that meet the diverse needs of patients with full-thickness wounds. By introducing a treatment option specifically for smaller wounds, we are expanding the accessibility of RECELL to a wider range of patients."
The Life360 share price is down 3% to $22.40. This follows a poor night of trade for tech stocks on Wall Street on Monday. It isn't just Life360 shares that are falling today, the tech sector is largely a sea of red. So much so, the S&P/ASX All Technology Index is down by around 1% at the time of writing.
The Newmont Corporation share price is down over 2% to $59.40. This follows a decline from the gold giant's shares on the New York Stock Exchange overnight after the gold price softened. This has led to the S&P/ASX All Ordinaries Gold index dropping 1.2% on Tuesday.
The St Barbara share price is down 4% to 22.5 cents. This gold miner's shares have been sold off this month after it was hit with a huge tax bill in Papua New Guinea. The country's Internal Revenue Commission (IRC) delivered correspondence to St Barbara's tax agent containing details of additional taxes, inclusive of a 200% penalty imposition, that amount to PGK 523 million. This is the equivalent of approximately A$210 million. St Barbara's CEO, Andrew Strelein, said "The receipt of this IRC Amended Assessment, backdating changes to 2008 and earlier, just as IRC were closing down its office for Christmas was disappointing – particularly when such positive progress has been made with Mineral Resources Authority and with Kumul Minerals Holdings Limited on the development of the Simberi Sulphides."
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。